Immune mediated pathways are now recognized to play a significant role in many common pathologies. The immune system comprises a complex series of interactions between cellular and molecular networks. The complexity arises mainly from the requirement to offer host defence against an almost infinite microbial pathogenic attach, together with a requirement to regulate matters such that host tissue damage is uncommon or at least limited. Failure of these complex regulatory pathways often leads to induction or amplification of pathology. Using rheumatoid arthritis as an exemplar, this lecture will consider the opportunities available for clinical intervention now arising as the molecular regulatory pathways in immune responses are unraveled. The clinical success of biologic agents that target cytokines e.g. tumour necrosis factor and interleukin-6 receptor provide definitive proof of concept that there are tractable checkpoints in the immune network. In future, as more information emerges as to how the immune system is organized in health and disease, it will become possible to intervene with greater discretion eventually to allow the re establishment of immune homeostasis -- that is the creation of immune tolerance. Such approaches offer the prospects for inflammatory disease anticipation, abrogation and even prevention. The potential for cellular modulatory pathways will be explored in novel models of breach of tolerance. Similarly new approaches to molecular complexity in the synovium in particularly concerning microRNAs will be described.
